Details for 2012860391

Up to date per 03.04.2026

Actions

Title / Product Name

SUBSTITUIERTE NUKLEOSIDE, NUKLEOTIDE UND ANALOGA DAVON

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2012860391

EP Publication Number

2794627

E-Number

1045920

Language

PCT Number

US12071063

Publication Date

29.10.2014 A

26.09.2018 B1

Registration Date

26.09.2018

AT Publication Date

15.10.2018

Application Date

20.12.2012

Registration Number

Priorities

22.12.2011

201161579560 P

21.03.2012

201261613836 P

IPC

C07H 19/00 20060101AFI20150317BHEP

Maximum Duration of Protection

20.12.2032

Owner

Janssen BioPharma, Inc.260-E Grand Avenue, 2nd Floor South San Francisco, CA 94080US

Representative

Häupl & Ellmeyer KG PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT

Inventor

BEIGELMAN, Leonid991 East Grant Place San Mateo, CA 94402US

WANG, Guangyi5066 Millay Court Calsbad, CA 92008US

SMITH, David, Bernard218 W. 40th Avenue San Mateo, CA 94403US

DEVAL, Jerome143 Carmel Ave. Pacifica, CA 94044US

PRHAVC, Marija1122 Cambria Way Encinitas, CA 92024US